US Medical Innovations, LLC

05/12/2022

Dr. Canady is Presenting a Two-year Follow-up of our Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at Israeli Society of Surgical Oncology

Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) and US Medical Innovations, LLC (USMI) announced today

05/03/2022

Learn more about Jeremy Benharouch's successful cancer surgery using Canady Helios™ Cold Plasma by the surgeon himself, Dr. Aviram Nissan. See the complete video here: https://www.usmedinnovations.com/

04/12/2022

Learn more about Jeremy Benharouch’s amazing story about how he’s been cancer-free for three years since his Canady Helios™ Cold Plasma treatment. To see the complete video, click here: https://www.usmedinnovations.com/

04/06/2022

Here is a video clip from our newest patient testimonial, "Inoperable to Operable, Jeremy's Story". To see the complete video and to learn more about Canady Helios(TM) Cold Plasma Technology, click here: https://www.usmedinnovations.com/

03/15/2022

Please check our our newest press release:

JCRI-ABTS’s scientists demonstrated that a combination of Canady Helios™ Cold Plasma (CHCP) and anti-BCL2A1 treatment may be beneficial and a novel therapeutic option for triple-negative breast cancer and other solid tumor cancers.

Jerome Canady Research Institute announces article:

12/22/2021

10/06/2021

USMI and JCRI Research Teams Develop Treatment System for COVID and other Respiratory Infections and Diseases

09/09/2021

USMI to Announce Successful Results of Phase I Clinical Trial using Cold Atmospheric Plasma for the Treatment of Solid Tumors at the Baird 2021 Global Healthcare Conference

Jerome Canady MD, USMI CEO, presents at the Baird Global Healthcare Conf. on Sept. 14; results of Phase 1 trials and apoptosis caused by Cold Plasma.

09/02/2021

JCRI Discovers the Mechanism using Canady Helios™ Cold Plasma to Induce Cell Death in Breast Cancer

Mechanism using Canady Helios™ Cold Plasma discovered to induce cell death in breast cancer

05/05/2021

USMI Developing the First Surgical Robot for Cancer Surgery

USMI announces the development of the First Surgical Robotic Plasma and Camera System for Cancer Surgery

04/28/2021

JCRI-ABTS and USMI Successfully Use Canady Helios™ Cold Plasma in Combination with FOLFIRINOX for the Treatment of Cholangiocarcinoma

US Medical Innovations published successful use of Canady Helios Cold Plasma in combination with FOLFIRINOX for the Treatment of Cholangiocarcinoma

04/20/2021

JCRI-ABTS and USMI Successfully Complete Phase 1 Multi-Center Clinical Trial Using Canady Helios™ Cold Plasma for the Treatment of Cancer

US Medical Innovations, LLC completed its clinical trial, phase 1, using Canady Helios™ Cold Plasma to treat recurrent and stage 4 solid tumors